Skip to content

Investigator

Kevin C O'connor

YALE UNIVERSITY · funded by NIAID, NINDS

Companies
1

Resolved onto their grants.

Grants
5

Federal awards on file.

Non-dilutive funding
$1.5M

Summed across those awards.

First award
Aug 1, 2015

Latest Jun 9, 2026.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R21

    Heterogeneity in autoimmune myasthenia gravis: classifying disease variants by unique immune mechanisms to inform personalized therapeutic strategies

    $252k

    Jun 9, 2026NIAIDYALE UNIVERSITYNIH RePORTER · 11349770 (opens the source filing in a new tab)

  2. R21

    Identifying new antigens in human autoantibody-mediated disease

    $251k

    Sep 2, 2025NIAIDYALE UNIVERSITYNIH RePORTER · 11215108 (opens the source filing in a new tab)

  3. U54

    Project 3

    $145k

    Sep 1, 2019NINDSGEORGE WASHINGTON UNIVERSITYNIH RePORTER · 11171997 (opens the source filing in a new tab)

  4. R01

    Mechanisms of autoimmunity in myasthenia gravis

    $335k

    Nov 4, 2015NIAIDYALE UNIVERSITYNIH RePORTER · 11127030 (opens the source filing in a new tab)

  5. R01

    Mechanisms of autoimmunity in myasthenia gravis

    $477k

    Aug 1, 2015NIAIDYALE UNIVERSITYNIH RePORTER · 10904878 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources